Madame Bioscience Public Company (MADAME) Fair Value & Analysis
Consumer Defensive · TH · Market cap 517M THB
Fair value as of: Jul 19, 2026
From 8 valuation models · updated 22 days ago
Share price +66.0% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from 0.6120 THB (bear) to 1.02 THB (bull), base 0.8160 THB. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 40/100 (below-average quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.
How to read this chart
60‑month range 0.4300 THB – 6.60 THB · fair‑value band 0.6120 THB – 1.02 THB · the 0.8300 THB price screens above the 0.8160 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 19, 2026.
Analysis
Madame Bioscience Public Company (MADAME) currently trades at 0.8300 THB, while our model-based Fair Value estimate is 0.8160 THB, implying the stock looks roughly 1.7% fairly valued today. The Quality Score stands at 40/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Madame Bioscience Public Company generated revenue of 1.5B THB at a net margin of -10.5%. Revenue grew 15.4% year over year. It earns a return on equity of -20.4%. Net debt stands at 60.0M THB. Fundamentals as of Jul 19, 2026
Our scenario range runs from 0.6120 THB (bear case) to 1.02 THB (bull case); at 0.8300 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 102% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -2%, MADAME screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 8 models by family
Widest divergence: DCF Models (1.33 THB) versus Earnings-Based (0.4700 THB). Highest evidence: Residual Income (76).
Notify me when MADAME reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 41 · Market factors (momentum, volatility) 51
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Madame Bioscience Public Company Limited, together with its subsidiaries, engages in the food business in Thailand. It operates through Packaging Business, Retail Sales of Cosmetics, Food Business, and Other Business segments.
Full company description
Madame Bioscience Public Company Limited, together with its subsidiaries, engages in the food business in Thailand. It operates through Packaging Business, Retail Sales of Cosmetics, Food Business, and Other Business segments. The company offers various food products, including frozen processed and ready-to-eat food, chilled food, plant-based food, hemp food, processed food, and sauces under the Kitchen Plus and Look Chin Tip brands. It also provides flexible packaging, polyethylene terephthalate bottles, and food packaging trays for packaged food and beverages. In addition, the company engages in the manufacture and sale of plastic packaging, seafood, and processed meat; retail sale of cosmetics; advertising rental services in gas stations; restaurant business; network marketing; and trading activities. The company was formerly known as Global Consumer Public Company Limited and changed its name to Madame Bioscience Public Company Limited in July 2025. Madame Bioscience Public Company Limited was founded in 1987 and is headquartered in Bangkok, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Madame Bioscience Public Company reported revenue of 1.5B THB in FY2025 versus 1.9B THB in FY2021, a compound −5.6%/yr. Reported net income was 45.8M THB in FY2025.
Watch MADAME: get an alert when its fair value changes →
Peer Group
Packaged Foods · 649 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare Madame Bioscience Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Madame Bioscience Public Company (MADAME) overvalued or undervalued?
What is the fair value of MADAME?
What is the quality score of MADAME?
What is the revenue of Madame Bioscience Public Company (MADAME)?
What is the net profit margin of MADAME?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Madame Bioscience Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.